Baden-Baden, December 8, 2022
Reckeweg Clinical Case Award Ceremony
From data to experience – sharing clinical experience through clinical case reports
Dr. David Riley
David Riley, founder of the Scientific Writing in Health and Medicine website, coauthor of the Case Reporting (CARE) guidelines, the editor of The Permanente Journal, and a member of the international expert review pane for the award gave the keynote lecture about sharing clinical experience through clinical case reports. He emphasized that case reports help establish effectiveness in treating individual patients, inspiring clinicians to improve their clinical experience.
Winner Case Presentation Lecture
Bioregulatory approach to autoinflammatory syndrome in a pediatric patient
Sandra Beltrán, Colombia
Dr. Beltran shared her experience in managing a pediatric patient with autoinflammatory syndrome using a bioregulatory approach. The patient had recurrent fever associated with skin manifestations and joint pain and did not respond to the usual management with antipyretics, anti-inflammatories, and corticosteroids – but did respond to bioregulatory therapy.
Clinical case of post-COVID cognitive disorders and asthenia in a young man: treatment options
Elena Kononova, Russia
Dr. Kononova wrote a clinical case report about a high school student suffering from post-COVID cognitive disorder and fatigue. This topic is highly relevant to many patients suffering from the post-COVID syndrome. This case demonstrates how a bioregulatory approach can support conventional therapy.
Dermatopathy of hepatobiliary origin. A comprehensive approach
Stephany Velasquez, Colombia
Dr. Velásquez told a story of a German Shepherd dog who suffered from skin lesions of hepatobiliary origin. She explained how skin changes might be used to identify liver disease, similar to human disease, and described an integrative approach using bioregulatory medicine. This clinical case is important because this condition has not been extensively described in canines.
All questions answered?
Still more questions?